Cipher Pharmaceuticals Inc.
CPH.TO
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 10.37M | 5.30M | 5.87M | 4.92M | 6.07M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.37M | 5.30M | 5.87M | 4.92M | 6.07M |
| Cost of Revenue | 1.97M | 1.11M | 1.06M | 955.00K | 1.08M |
| Gross Profit | 8.40M | 4.20M | 4.81M | 3.97M | 4.99M |
| SG&A Expenses | 4.61M | 1.32M | 1.47M | 1.29M | 1.69M |
| Depreciation & Amortization | 1.93M | 292.00K | 289.00K | 273.00K | 269.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.50M | 2.72M | 2.81M | 2.55M | 3.05M |
| Operating Income | 1.87M | 2.59M | 3.06M | 2.37M | 3.02M |
| Income Before Tax | 326.00K | 2.52M | 2.97M | 3.68M | 3.12M |
| Income Tax Expenses | 43.00K | -480.00K | -1.96M | -3.97M | -3.91M |
| Earnings from Continuing Operations | 283.00K | 3.00M | 4.92M | 7.66M | 7.03M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 283.00K | 3.00M | 4.92M | 7.66M | 7.03M |
| EBIT | 1.87M | 2.59M | 3.06M | 2.37M | 3.02M |
| EBITDA | 3.80M | 2.88M | 3.34M | 2.55M | 3.29M |
| EPS Basic | 0.01 | 0.12 | 0.21 | 0.32 | 0.28 |
| Normalized Basic EPS | 0.05 | 0.07 | 0.08 | 0.09 | 0.08 |
| EPS Diluted | 0.01 | 0.12 | 0.20 | 0.30 | 0.27 |
| Normalized Diluted EPS | 0.05 | 0.07 | 0.08 | 0.09 | 0.08 |
| Average Basic Shares Outstanding | 25.17M | 24.11M | 23.99M | 24.26M | 25.31M |
| Average Diluted Shares Outstanding | 25.69M | 24.57M | 24.40M | 24.78M | 25.70M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
